Page last updated: 2024-08-21

methionine sulfoximine and etoposide

methionine sulfoximine has been researched along with etoposide in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's5 (71.43)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lafleur, MV; Lankelma, J; Mans, DR; Pinedo, HM; Retèl, J; Schuurhuis, GJ; Treskes, M1
Hotta, T; Kawamoto, K; Kiya, K; Kurisu, K; Mikami, T; Nakada, Y; Saito, Y; Uozumi, T; Yamada, K1
Larsson, R; Nygren, P1
Ardiet, C; Navarro, C; Sapet, C; Tranchand, B1
Ciriolo, MR; Coppola, S; Ghibelli, L; Lafavia, E; Maresca, V; Rotilio, G1
Cowan, KH; Schneider, E; Sinha, BK; Yamazaki, H1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1

Other Studies

7 other study(ies) available for methionine sulfoximine and etoposide

ArticleYear
Modulation by D,L-buthionine-S,R-sulphoximine of etoposide cytotoxicity on human non-small cell lung, ovarian and breast carcinoma cell lines.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:8-9

    Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Buthionine Sulfoximine; Carcinoma, Non-Small-Cell Lung; Cisplatin; Doxorubicin; Drug Synergism; Etoposide; Female; Glutathione; Humans; Lung Neoplasms; Methionine Sulfoximine; Ovarian Neoplasms; Tumor Cells, Cultured; Verapamil

1992
Glutathione and cellular response of ACNU-resistant rat glioma sublines to drugs and radiation.
    International journal of cancer, 1991, Jul-30, Volume: 48, Issue:6

    Topics: Animals; Buthionine Sulfoximine; Cell Line; Cell Survival; Dose-Response Relationship, Radiation; Doxorubicin; Drug Resistance; Etoposide; Glioma; Glutathione; Kinetics; Methionine Sulfoximine; Nimustine; Pyrrolidonecarboxylic Acid; Rats; Thiazoles; Thiazolidines; Vinblastine

1991
Differential in vitro sensitivity of human tumor and normal cells to chemotherapeutic agents and resistance modulators.
    International journal of cancer, 1991, Jun-19, Volume: 48, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Agents; Buthionine Sulfoximine; Cell Division; Cell Line; Cell Survival; Cisplatin; Cyclosporins; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Humans; Kidney Neoplasms; Kinetics; Leukemia; Lymphocytes; Methionine Sulfoximine; Neurilemmoma; Tumor Cells, Cultured; Verapamil; Vincristine

1991
[Cellular pharmacokinetics of melphalan alone or in combination on human lymphoma or lymphoblasts].
    Bulletin du cancer, 1989, Volume: 76, Issue:8

    Topics: Antimetabolites; Blastomeres; Burkitt Lymphoma; Buthionine Sulfoximine; Cell Line; Etoposide; Humans; Lymphocytes; Melphalan; Methionine Sulfoximine; Verapamil

1989
Non-oxidative loss of glutathione in apoptosis via GSH extrusion.
    Biochemical and biophysical research communications, 1995, Nov-02, Volume: 216, Issue:1

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Buthionine Sulfoximine; Cell Line; Cycloheximide; Etoposide; Glutathione; Humans; Hydrogen Peroxide; Kinetics; L-Lactate Dehydrogenase; Methionine Sulfoximine; Oxidation-Reduction; Oxidative Stress; Puromycin

1995
Buthionine sulphoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation.
    British journal of cancer, 1995, Volume: 71, Issue:4

    Topics: Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Buthionine Sulfoximine; Cell Line; Cell Survival; Drug Resistance, Multiple; Etoposide; Female; Glutathione; Humans; Kinetics; Methionine Sulfoximine; Tumor Cells, Cultured; Vincristine

1995
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007